0.00Open0.11Pre Close0 Volume5 Open Interest62.00Strike Price0.00Turnover521.40%IV19.62%PremiumDec 13, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.11Extrinsic Value100Contract SizeAmericanOptions Type-0.0290Delta0.0070Gamma699.97Leverage Ratio-1.4752Theta0.0000Rho-20.32Eff Leverage0.0012Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet